{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:26:49Z","timestamp":1794576409899,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82022065"],"award-info":[{"award-number":["82022065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2020QNXZ0017"],"award-info":[{"award-number":["2020QNXZ0017"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013494","name":"West Light Foundation of the Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2019BFG02017"],"award-info":[{"award-number":["2019BFG02017"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2021ZDYF0637"],"award-info":[{"award-number":["2021ZDYF0637"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113599","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:05:36Z","timestamp":1622869536000},"page":"113599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury"],"prefix":"10.1016","volume":"222","author":[{"given":"Le","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113599_bib1","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113599_bib2","doi-asserted-by":"crossref","first-page":"110643","DOI":"10.1016\/j.biopha.2020.110643","article-title":"Drug repurposing of anti-infective clinical drugs: discovery of two potential anti-cytokine storm agents","volume":"131","author":"Su","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113599_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.60.3.233","article-title":"The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management","volume":"60","author":"Petty","year":"1971","journal-title":"Chest"},{"key":"10.1016\/j.ejmech.2021.113599_bib4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0140-6736(07)60604-7","article-title":"Acute lung injury and the acute respiratory distress syndrome: a clinical review","volume":"369","author":"Wheeler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113599_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute lung injury review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113599_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/ars.2007.1940","article-title":"Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome","volume":"10","author":"Tasaka","year":"2008","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2021.113599_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury","volume":"133","author":"Imai","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113599_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2014.01.028","article-title":"Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-kappaB pathway","volume":"69","author":"Yeh","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113599_bib9","doi-asserted-by":"crossref","first-page":"112734","DOI":"10.1016\/j.ejmech.2020.112734","article-title":"Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions","volume":"207","author":"Lu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101565","article-title":"A\u00a0hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions","volume":"34","author":"Lu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2021.113599_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101266","article-title":"A\u00a0potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-kappaB activation","volume":"26","author":"Lu","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2021.113599_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14756366.2018.1461856","article-title":"Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy","volume":"33","author":"Jiang","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2018.02.010","article-title":"Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis","volume":"117","author":"Meng","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113599_bib14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.cclet.2020.08.049","article-title":"Radiosensitization of human pancreatic cancer by piperlongumine analogues","volume":"32","author":"Ma","year":"2020","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113599_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2020.06.028","article-title":"Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease","volume":"159","author":"Qu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113599_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113599_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2021.113599_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113599_bib19","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/acs.jmedchem.9b01865","article-title":"Emerging substrate proteins of Kelch-like ECH associated protein 1 (Keap1) and potential challenges for the development of small-molecule inhibitors of the Keap1-nuclear factor erythroid 2-related factor 2 (Nrf2) protein-protein interaction","volume":"63","author":"Zhang","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib20","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib21","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1021\/acs.jmedchem.0c02094","article-title":"Deconstructing noncovalent Kelch-like ECH-associated protein 1 (Keap1) inhibitors into fragments to reconstruct new potent compounds","volume":"64","author":"Pallesen","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein-protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113599_bib23","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1021\/jm400224q","article-title":"Keap calm, and carry on covalently","volume":"56","author":"Wilson","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2021.113599_bib25","doi-asserted-by":"crossref","first-page":"113030","DOI":"10.1016\/j.ejmech.2020.113030","article-title":"Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors","volume":"212","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib26","doi-asserted-by":"crossref","first-page":"9965","DOI":"10.1021\/acs.jmedchem.0c01088","article-title":"CDDO-imidazolide targets multiple amino acid residues on the Nrf2 adaptor, Keap1","volume":"63","author":"Meng","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib27","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1021\/jacs.0c09799","article-title":"Recapitulating the binding affinity of Nrf2 for KEAP1 in a cyclic heptapeptide, guided by NMR, X-ray crystallography, and machine learning","volume":"143","author":"Ortet","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113599_bib28","doi-asserted-by":"crossref","first-page":"112532","DOI":"10.1016\/j.ejmech.2020.112532","article-title":"Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors","volume":"202","author":"Mou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1021\/acsmedchemlett.9b00594","article-title":"Combined peptide and small-molecule approach toward nonacidic THIQ inhibitors of the KEAP1\/NRF2 interaction","volume":"11","author":"Ontoria","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113599_bib30","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1021\/acs.jmedchem.0c01116","article-title":"Design, synthesis, and structure-activity relationships of indoline-based Kelch-like ECH-associated protein 1-nuclear factor (Erythroid-Derived 2)-like 2 (Keap1-Nrf2) protein-protein interaction inhibitors","volume":"63","author":"Zhou","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2174\/0929867321666140217104648","article-title":"Updated research and applications of small molecule inhibitors of Keap1-Nrf2 protein-protein interaction: a review","volume":"21","author":"Zhuang","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113599_bib33","doi-asserted-by":"crossref","first-page":"104172","DOI":"10.1016\/j.bioorg.2020.104172","article-title":"Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease","volume":"103","author":"Sun","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ejmech.2018.12.011","article-title":"Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR\/Akt pathway inhibitors","volume":"163","author":"Khan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib35","doi-asserted-by":"crossref","first-page":"111693","DOI":"10.1016\/j.ejmech.2019.111693","article-title":"New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: design, synthesis, cytotoxicity evaluation and in silico studies","volume":"183","author":"El-Sayed","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.intimp.2012.07.007","article-title":"Kaempferol regulates MAPKs and NF-kappaB signaling pathways to attenuate LPS-induced acute lung injury in mice","volume":"14","author":"Chen","year":"2012","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2021.113599_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ni1200","article-title":"ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity","volume":"6","author":"Matsuzawa","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2021.113599_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113599_bib39","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.160.6.9901117","article-title":"Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS","volume":"160","author":"Greene","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:29:04Z","timestamp":1759328944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421004487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S0223523421004487"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113599","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113599"}}